| |
| |
|
| Insider
Information: |
Brumm Joshua T |
| Relationship: |
|
| City: |
Pleasanton |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
746,959 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,159,447 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
746,959 |
|
|
| Total
Value |
$17,159,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 267.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zeltiq Aesthetics Inc |
ZLTQ |
VP of Corporate Develo... |
2012-02-17 |
7,692 |
2012-02-17 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
COO and CFO |
2017-10-19 |
201,269 |
2014-04-15 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-11 |
537,998 |
2020-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZLTQ |
Zeltiq Aesthetics Inc |
VP of Corporate Development |
• – – |
2012-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,692 |
7,692 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
107,027 |
107,027 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2021-09-20 |
4 |
AS |
$15.61 |
$53,464 |
D/D |
(3,425) |
103,602 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2021-09-21 |
4 |
AS |
$16.11 |
$73,848 |
D/D |
(4,584) |
99,018 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2021-10-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,500 |
95,518 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
118,190 |
213,708 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-03-11 |
4 |
AS |
$8.73 |
$29,542 |
D/D |
(3,384) |
210,324 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-06-14 |
4 |
D |
$4.95 |
$17,523 |
D/D |
(3,540) |
206,784 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,118 |
230,902 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-07-06 |
4 |
D |
$8.24 |
$90,335 |
D/D |
(10,963) |
219,939 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-09-15 |
4 |
D |
$14.05 |
$48,894 |
D/D |
(3,480) |
216,459 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-09-20 |
4 |
D |
$13.70 |
$162,153 |
D/D |
(11,836) |
204,623 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-07 |
4 |
OE |
$1.03 |
$14,626 |
D/D |
14,200 |
218,823 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-07 |
4 |
S |
$13.37 |
$189,854 |
D/D |
(14,200) |
204,623 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,500 |
189,123 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-10 |
4 |
S |
$12.46 |
$2,439,668 |
D/D |
(195,800) |
204,623 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-10 |
4 |
OE |
$1.03 |
$201,674 |
D/D |
195,800 |
400,423 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
144,000 |
333,123 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-12-12 |
4 |
AS |
$10.87 |
$36,110 |
D/D |
(3,322) |
329,801 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
S |
$13.15 |
$806,690 |
D/D |
(61,000) |
269,771 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
OE |
$1.03 |
$30,991 |
D/D |
30,088 |
330,771 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,800 |
300,683 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-09 |
4 |
S |
$13.34 |
$1,021,604 |
D/D |
(76,582) |
269,771 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-09 |
4 |
OE |
$1.03 |
$78,879 |
D/D |
76,582 |
346,353 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-12 |
4 |
S |
$12.61 |
$2,367,502 |
D/D |
(187,748) |
253,383 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
